Keros Therapeutics Inc (KROS)

05:57 AM

Is Keros Therapeutics Inc. forming a breakout pattern2025 Risk Factors & Consistent Income Trade Recommendations - thegnnews.com

05:57 AM

02:45 AM

What makes Keros Therapeutics Inc. stock price move sharply2025 Key Lessons & Weekly High Return Stock Opportunities - thegnnews.com

02:45 AM

06:53 AM

40,245 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Purchased by Tejara Capital Ltd - MarketBeat

06:53 AM

Aug 16, 2025

Is Keros Therapeutics Inc. stock trending bullish2025 Winners & Losers & Target Return Focused Picks - thegnnews.com

Aug 16, 2025

Aug 15, 2025

Keros Therapeutics Inc. Breaks Below Key Support LevelJuly 2025 Levels & Safe Entry Point Alerts - sundaytimes.kr

Aug 15, 2025

Aug 14, 2025

Leerink Partnrs Has Negative Estimate for KROS Q3 Earnings - MarketBeat

Aug 14, 2025

Aug 14, 2025

Q3 EPS Estimate for Keros Therapeutics Lowered by Analyst - MarketBeat

Aug 14, 2025

Aug 14, 2025

Technical Bounce Expected in Keros Therapeutics Inc. Next Week2025 Year in Review & Community Consensus Picks - thegnnews.com

Aug 14, 2025

Aug 14, 2025

Keros Therapeutics Reports Strong Revenue Growth - TipRanks

Aug 14, 2025

Aug 12, 2025

XTX Topco Ltd Invests $490,000 in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Aug 12, 2025

Aug 12, 2025

Keros Therapeutics (NASDAQ:KROS) Price Target Cut to $20.00 by Analysts at HC Wainwright - MarketBeat

Aug 12, 2025

Aug 08, 2025

Leerink Partners Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛

Aug 08, 2025

Aug 08, 2025

Keros Therapeutics stock price target lowered to $20 at H.C. Wainwright - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Strategic Focus on KER-065 and Leadership Changes Justify Buy Rating for Keros Therapeutics - TipRanks

Aug 08, 2025

Aug 08, 2025

Keros prioritizes KER-065, pulls plug on cibotercept - The Pharma Letter

Aug 08, 2025

Aug 08, 2025

Keros Therapeutics’ Workforce Cuts: Potential Savings vs. Strategic Risks - TipRanks

Aug 08, 2025

Aug 07, 2025

Wedbush Maintains Keros Therapeutics(KROS.US) With Hold Rating, Maintains Target Price $15 - 富途牛牛

Aug 07, 2025

Aug 07, 2025

Keros Therapeutics to discontinue cibotercept, announces COO departure - TipRanks

Aug 07, 2025

Aug 07, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Holdings Raised by Federated Hermes Inc. - MarketBeat

Aug 07, 2025

Aug 06, 2025

Keros Therapeutics: Strategic Shift and Organizational Changes Prompt Hold Rating - TipRanks

Aug 06, 2025

Aug 06, 2025

Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Aug 06, 2025

Aug 06, 2025

Keros Therapeutics Announces Strategic Realignment and Leadership Changes - TipRanks

Aug 06, 2025

Aug 06, 2025

Keros Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025

Aug 06, 2025

Keros discontinues cibotercept development, announces leadership changes By Investing.com - Investing.com South Africa

Aug 06, 2025

Aug 06, 2025

Keros discontinues cibotercept development, announces leadership changes - Investing.com

Aug 06, 2025

Aug 06, 2025

Keros Therapeutics Announces Discontinuation of Cibotercept Development and Leadership Changes for Strategic Realignment - Quiver Quantitative

Aug 06, 2025

Aug 06, 2025

Keros Transforms Pipeline: Focuses All Resources on Promising DMD Drug KER-065 as Phase 2 Trial Approaches - Stock Titan

Aug 06, 2025

Aug 06, 2025

Keros Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 06, 2025

Aug 03, 2025

Is it the right time to buy Keros Therapeutics Inc. stockGet timely alerts on top market movers - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Published on: 2025-08-03 17:03:57 - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Keros Therapeutics Inc. Stock Analysis and ForecastCapitalize on momentum-driven investment opportunities - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Keros Therapeutics Inc. compare to its industry peersBuild wealth faster with consistent investment plans - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Keros Therapeutics Inc. in the next 12 monthsAchieve breakthrough profits with expert advice - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Keros Therapeutics Inc. company’s key revenue driversUnlock exclusive stock market forecasts - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the technical indicators suggesting about Keros Therapeutics Inc.Unlock powerful portfolio optimization tools - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $30.56 Average Price Target from Analysts - MarketBeat

Aug 03, 2025

Aug 02, 2025

What catalysts could drive Keros Therapeutics Inc. stock higher in 2025Unlock powerful portfolio management tools - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

How strong is Keros Therapeutics Inc. company’s balance sheetGain the edge with real-time market data - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Keros Therapeutics Inc. stock overvalued or undervaluedExceptional market performance - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How volatile is Keros Therapeutics Inc. stock compared to the marketRapid wealth creation - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Why is Keros Therapeutics Inc. stock attracting strong analyst attentionPowerful market insights - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Does Keros Therapeutics Inc. stock perform well during market downturnsEarnings Report Growth Plan For Smart Trading - Jammu Links News

Aug 01, 2025